Atlas Trials

A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 Years

Clinical trial NCT04421105 · COMPLETED

Trial details

NCT number
NCT04421105
Sponsor
Eleusis Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2015-06-29
Primary completion
2015-10-30
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.